Сулцеф

Сулцеф is a combination antibiotic containing Cefoperazone Sodium and Sulbactam Sodium, designed for intramuscular and intravenous use. It is used to treat bacterial infections by inhibiting bacterial cell wall synthesis. This product is manufactured by Medochemie Ltd. and is available in the EU market.

Сулцеф is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. It may also be prescribed for infections caused by susceptible bacteria, such as those affecting the bones and joints. This antibiotic is effective against a broad spectrum of gram-positive and gram-negative bacteria.

Сулцеф works by disrupting the formation of bacterial cell walls, leading to bacterial death. It combines a beta-lactam antibiotic (Cefoperazone) with a beta-lactamase inhibitor (Sulbactam) to enhance its effectiveness against resistant bacteria. Patients may experience symptom improvement within a few days of starting treatment.

Сулцеф should be handled with care, especially by individuals with known allergies to cephalosporins or penicillins. It is important to follow medical guidance regarding administration and storage. Keep the product in a cool, dry place away from direct sunlight. Always use sterile techniques when preparing and administering the medication.

Сулцеф may interact with other medications, including anticoagulants, diuretics, and certain antibiotics. Alcohol consumption should be avoided during treatment due to potential adverse effects. Patients should inform their healthcare provider about all medications and supplements they are taking to prevent potential interactions.